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Abstract
To accurately measure menthol levels in human urine, we developed a method using gas 
chromatography/electron ionization mass spectrometry with menthol-d4 stable isotope internal 
standardization. We used solid phase microextraction (SPME) headspace sampling for collection, 
preconcentration and automation. Conjugated forms of menthol were released using β-
glucuronidase/sulfatase to allow for measuring total menthol. Additionally, we processed the 
specimens without using β-glucuronidase/sulfatase to quantify the levels of unconjugated (free) 
menthol in urine. This method was developed to verify mentholated cigarette smoking status to 
study the influence of menthol on smoking behaviour and exposure. This objective was 
accomplished with this method, which has no carryover or memory from the SPME fiber 
assembly, a method detection limit of 0.0017 μg/mL, a broad linear range of 0.002–0.5 μg/mL for 
free menthol and 0.01 – 10 μg/mL for total menthol, a 7.6% precision and 88.5% accuracy, and an 
analysis runtime of 17 min. We applied this method in analysis of urine specimens collected from 
cigarette smokers who smoke either mentholated or non-mentholated cigarettes. Among these 
smokers, the average total urinary menthol levels was three-fold higher (p <0.001) among 
mentholated cigarette smokers compared with non-mentholated cigarette smokers.
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Menthol is a naturally occurring compound with topical cooling and anesthetic properties 
used in a wide range of products including common cold medications, toothpastes, 
confectionery, pesticides, and cigarettes. Relevant to this study is its use as a flavor additive 
in milligram quantities (typically as L-menthol) in mentholated cigarettes. Although menthol 
is not considered a carcinogen, it may increase carcinogen uptake by numbing the 
respiratory tract so that smoke is inhaled deeper and held longer. Indeed, the high prevalence 
of mentholated cigarette use among African Americans has been hypothesized to explain 
this population’s disproportionately higher lung cancer risk per cigarette smoked (menthol 
cigarettes smoked by >88% vs. 26% for whites).[1]
Results from studies evaluating the association between mentholated cigarette usage and 
increased lung cancer risk have been varied. [2–6] For example, a Kaiser Permanente study 
conducted between 1979 and 1986 found a statistically significant increase in risk for 
menthol cigarette smokers.[2] In males, the relative risk for menthol smokers was 1.45 (95% 
confidence interval 1.03–2.02). In females, the relative risk was 0.75 (95% confidence 
interval 0.52–1.11). On the contrary, the Southern Community Cohort Study, found a 
statistically significant reduced risk of lung cancer in non-mentholated smokers vs. 
mentholated cigarette smokers.[7] To better understand conflicting studies and discern the 
influences of menthol on smoking behavior and associated health outcomes, a highly 
accurate and precise analytical method to verify biomarkers of menthol exposure is 
necessary.
Several researchers have investigated menthol analysis methods for biological specimens. 
Although high pressure liquid chromatography/mass spectrometry (HPLC/MS) has been 
demonstrated,[8] most method development has involved gas chromatography (GC) 
separation, because menthol is still within the realm of a volatile organic compound, with a 
boiling point of 212 °C and thermal stability.[9,10] As a result, GC methods have yielded 
better sensitivity than LC methods by at least two orders of magnitude, especially when 
combined with mass spectrometric detection. In 2004, Spichiger et al. incorporated solid 
phase microextraction (SPME) as a means to preconcentrate menthol collected in the 
headspace (HS) over urine and serum specimens before and after hydrolysis of menthol 
glucuronide adducts.[11] This SPME method experienced persistent background levels, 
especially for urine specimens, possibly from menthol penetration within the SPME fiber 
assembly caused by a high (80 °C) collection temperature and a relatively long (20 min) 
collection time. Schulz et al. used a similar method to measure menthol and three other 
compounds in serum specimens lowering the collection temperature to 50 °C over a 30 min 
collection time. They reported no carryover or memory, but a similar limit of detection 
(LOD) of 0.0046 μg/mL for the analysis of serum specimens.[12] However, analysis of 
menthol in urine is advangateous to analysis in serum because urine collection is non-
invasive and menthol is readily partitioned from urine, which is a more polar matrix than 
serum. Moreover, menthol persists longer in urine than in blood[13] with an α-phase half-
life of 56.2 min for blood vs. 74.9 min for urine.
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Here we present an improved GC/MS method for analysis of free menthol and total menthol 
in urine specimens using a HS/SPME based method that eliminates carryover from the 
SPME fiber assembly. Our improved GC/MS method is validated with internal quality 
control, performance testing, and subsequent method verification involving analysis of 
menthol levels in urine from non-mentholated and mentholated cigarette smokers.
2. Experimental
2.1. Chemicals
Native L(−)-menthol (5-methyl-2-[1-methylethyl]cyclohexanol, 99.7%), mentholglucuronic 
acid ammonium salt, Type H-1 β–D-glucuronidase/sulfatase (Type H-1, from Helix 
pomatia), trisodium citrate dihydrate (SigmaUltra grade), and citric acid monohydrate (ACS 
reagent grade) were purchased from Sigma Chemical Company (St. Louis, MO, USA). (−)-
Menthol-1,2,6,6-d4 (98%) was purchased from Cambridge Isotope Lab (Andover, MA, 
USA). Water (HPLC grade) was purchased from J.T. Baker (Phillipsburg, NJ, USA), and 
methanol (GC2 Capillary GC/GC-MS grade) was purchased from Burdick and Jackson 
(Muskegon, MI, USA). Helium gas for GC/MS (ultra high-purity grade) was purchased 
from Airgas Inc. (Jacksonville, FL, USA).
2.2. Urine Specimen Collection
The method was applied to urine collected from established smokers (i.e., individuals who 
smoked at least 6 cigarettes per day for at least the past three years). Pregnant participants, 
participants arriving intoxicated to any visit, and participants with self-reported smoking-
related diseases were excluded. Participants signed informed consent documents and 
subsequently provided urine specimens. The study protocol was approved by CDC’s 
institutional review board. Urine from 95 smokers was used to verify this method. Smokers 
consisted of 26 non-mentholated and 68 mentholated cigarettes smokers.
This study was approved by the Battelle Centers for Public Health and Research Evaluation 
(CPHRE) Institutional Review Board (IRB# FG465925-04) to ensure the protection of 
participants’ safety, rights, and welfare. The Center for Disease Control and Prevention’s 
(CDC) role was limited to analysis of coded specimens and was determined to not constitute 
engagement in human subjects research.
2.3. Urine Specimen Preparation
Unknown specimens were prepared in 10 mL headspace SPME vials obtained from 
MicroLiter Analytical Supplies Inc. (Suwanee, GA, USA). For free menthol measurement, 
100 μL of urine, 100 μL of 0.1 M trisodium citrate dihydrate buffer (pH 5.0), and 50 μL of 5 
μg/mL menthol-d4 internal standard solution were added to the vial. The total liquid volume 
was 0.25 mL. For total menthol measurements, the buffer was replaced with the same 
volume of an enzyme solution that was made by adding β-D-glucuronidase into the buffer at 
a concentration of 3 mg/mL. The SPME vial was then sealed with a 1-mm thick, 20-mm 
PTFE/silicone septum (Supelco, St. Louis, MO, USA) and capped using a M-10 flat washer 
spacer (Hillman, Cincinnati, OH, USA) and a 20-mm open-center steel seal (Supelco, St. 
Louis, MO, USA). Specimens prepared for free menthol measurement were ready to analyze 
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immediately. Specimens prepared for total menthol measurement were put into an oven and 
incubated at 37 °C for 24 hr to ensure complete deconjugation of the menthol glucuronide. 
Once samples are ready for analysis they equilibrate on the PAL autosampler in queue for 
approximately 5 hrs as instrument and fiber blanks, standards and QCs are run.
2.4. Standards Preparation
All standards were prepared identically to unknown specimens with the exception of 
replacing 100 μL urine with 100 μL synthetic urine (CTSI, Great Neck, NY, USA). For total 
menthol measurement, the calibration curve consisted of 6 points (0.01, 0.1, 0.5, 2, 5, and 10 
μg/mL). For free menthol measurement, the calibration curve consisted of 8 points (0.001, 
0.002, 0.005, 0.01, 0.02, 0.05, 0.1, and 0.5 μg/mL).
2.5 Characterization of Quality Control (QC) Samples
Total and free quality control pool samples were characterized prior to any urine specimen 
analysis by spiking menthol or menthol glucuronide into an anonymously donated and 
homogenized urine pool. Total menthol QC pools were prepared at two different levels by 
adding an aqueous solution of mentholglucuronic acid ammonium salt into the urine pools to 
achieve the desired levels. These total menthol QC samples were characterized from 20 
independent batches within a 5-month period, using the same deconjugation method as for 
the specimens. This determination yielded mean concentrations of 1.43 ± 0.08 μg/mL (N = 
20) for the total QC low (TQCL) pool and 8.77 ± 0.50 μg/mL (N=20) for the total QC high 
(TQCH) pool.
Free menthol QC pools were prepared at two different levels by adding menthol solution to 
urine pools to achieve characterized levels of 0.039 ± 0.004 μg/mL (N = 13) for the free QC 
low (FQCL) pool and 0.267 ± 0.033 μg/mL (N=14) for the free QC high (FQCH) pool. The 
concentrations for both the total menthol and free menthol QC pools reflect the sum of the 
background levels in the anonymous urine and the spiked amount.
A typical run included at least four QC samples where a QC low and QC high bracketed the 
unknown specimens. The two samples from the same QC pool were averaged. All 
measurements within a run batch were considered invalid if: (1) the difference between the 
two averaged QCs was within a factor of 4 of the SD of the independent characterization 
QCs, (2) the level of QC low or QC high was more than 3 SDs of the characterized mean, 
(3) both QC low and QC high concentrations were outside 2 SD limits, and (4) the previous 
9 consecutive QC results fall on the same side of the mean for either QC low or QC high.
2.6. HS-SPME Extraction
Headspace SPME extraction was performed automatically using a PAL auto-sampler (CTC 
Analytics AG, Zwingen, Switzerland) and a 65-μm polydimethylsiloxane/divinylbenzene 
(PDMS/DVB) fiber (Supelco Inc., St. Louis, MO, USA). For total menthol measurement, 
the fiber was exposed to the headspace for 1 min at 30 °C. For free menthol measurement, 
the fiber was exposed to the headspace for 3 min at 50 °C. In both cases, the sample was 
agitated at 500 rpm by the agitator tray during the entire extraction time. After headspace 
extraction the fiber was immediately transferred to the GC injection port where analytes 
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were thermally desorbed. To minimize fiber contamination with volatiles in laboratory air, 
the fiber remained in the GC inlet for the remainder of the GC run.
2.7. GC-MS Conditions
Analyses were performed on an Agilent 6890 gas chromatograph coupled with an Agilent 
5973 mass selective detector. The GC was equipped with a 2-mm inner diameter (ID) liner 
at the inlet and a Hewlett Packard HP-5 trace analysis column (30 m × 0.25 mm ID × 1.0 μm 
film thickness). The injection port and transfer line were both maintained at 250 °C 
throughout the run. The oven temperature started at 50 °C and immediately ramped up to 
135 °C at 10 °C/min, followed by 15 °C/min to 260 °C. Total runtime was 17 min. Helium 
was used as carrier gas at a flow rate of 1.0 mL/min. The MS system was operated using 
electron impact ionization and in selected ion monitoring (SIM) mode. Ion m/z 138 was 
used to quantify native menthol, m/z 142 was used to quantify internal standard, and m/z 
123 was used as the confirmation ion.
2.8. Quantification
Original chromatograms were analyzed by ChemStation software. Manual integration of 
native menthol (m/z 138) and internal standard (m/z 142) peaks was often needed. Data was 
then transferred to Xcalibur Quan Browser software (ThermoFinnigan, San Jose, CA, USA) 
where the native-to-internal standard ion ratio, in relation to the calibration curve acquired 
the same day, was used to quantitatively determine urinary menthol concentrations. Final 
data was transferred to an in-house laboratory information system, ATLIS (Microsoft 
Access-based database), using a visual basic module to import the Excel (Microsoft, Seattle, 
WA, USA) report generated by Quan Browser into the database.
In this study creatinine was measured in each urine specimen photometrically using the 
Boehringer Mannheim/Hitachi 912 analyzer (Roche Diagnostics Corporation, Indianapolis, 
IN, USA). The creatinine-corrected urinary menthol level was calculated as the ratio of the 
measured menthol to the measured creatinine concentration.
2.9. Statistical Analysis and Calculations
Descriptive statistical analyses were performed using JMP (Version 8.0, SAS, Cary, NC, 
USA).
3. Results and Discussion
This automated method was developed to accurately quantify a broad range of free and total 
menthol levels in urine to support large exposure assessment studies. As such, this method 
achieves high throughput, minimizes sample handling, and eliminates carryover from the 
SPME fiber assembly. The current approach involves homogenizing an aliquot of urine with 
buffer and an isotopically labelled analog ISTD in a headspace vial, which is sampled by 
equilibrium headspace SPME and then analyzed by GC/MS. Automation of the SPME 
sampling is accomplished on a CTC platform.
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In SPME analysis of high boiling point VOCs such as menthol, absorption of VOCs into the 
sealing septum of the SPME fiber assembly can result in carryover and raise the LOD. To 
minimize carryover, we lowered the collection efficiency by using both short collection 
times and low equilibration temperatures. For the analysis of free menthol, we used a 3-min 
collection time with a 50 °C equilibration temperature and for total menthol we used a 1-min 
collection time and a 30 °C equilibration temperature. Because quantification is based on the 
use of an internal standard, higher concentrations can be quantified at lower extraction 
efficiencies and is advantageous in analyzing unknowns where concentration from one 
sample to the next can vary over two orders of magnitude. This approach resulted in optimal 
analytical figures of merit as described below.
3.1. Instrument Calibration Characteristics
Using this SPME GS/MS method, the instrument response to menthol remained linear up to 
10 μg/mL with linear coefficients of determination (R2) often greater than 0.9996. On 
average (N = 32) the linear least squares prediction equation determined from calibrator 
responses was y = −0.0043 (± 0.0116) + 1.359 (± 0.130) x, where y was the area ratio of the 
primary quantification ion (m/z 138) to the ISTD ion (m/z 142) and × was the calibration 
standard concentration in μg/mL The y-intercept near 0 indicates minimal background 
contamination or spectral interference.
3.2. Selectivity
For this SPME GC/MS method the native menthol peak elutes at 11.65 min and the d4-
labelled internal standard elutes at 11.62 min. Example selected ion chromatograms at m/z 
138 (native) and m/z 142 (labeled ISTD) for an unknown urine specimen with a 
concentration measured at 0.86 μg/mL is shown for in Fig. 1. No interfering peaks were 
observed in urine specimen throughout the method development and specimen analyses.
3.3. Method Detection Limit (MDL)
The MDL for this method was calculated to be 0.0017 μg/mL based on three times the 
standard deviation (SD) at zero concentration (3S0) in an synthetic urine matrix.[14] The S0 
value was deduced by extrapolating the linear regression equation for the corresponding SD 
versus concentrations (at least three) nearest the detection limit. If calculated MDL was 
lower than the lowest calibration standard, the lowest calibration standard was used as 
lowest reportable limit, which was 0.01 μg/mL for total menthol, and 0.002 μg/mL for free 
menthol.
3.4. SPME Fiber Selection
Because bipolar compounds, such as menthol, are often most efficiently extracted with fiber 
coatings containing both a polar and nonpolar phase,[15] three different two-phase SPME 
fibers were evaluated for headspace extraction in urinary menthol measurement (Table 1). 
Both 65 μm PDMS/DVB and 65 μm carbowax/divinylbenzene (CW/DVB) showed 
comparable extraction efficiency and low carryover effect (e.g., < 0.02%), Even though 
Carboxen and DVB have roughly the same surface area, Carboxen/PDMS had extraction 
efficiencies that were 1.7–2.8 times lower than the PDMS/DVB. Because the Carboxen/
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PDMS is more polar than either PDMS/DVB or CW/DVB, lower efficiency may be 
attributed to increased competition effects or poorer desorption efficiency of menthol from 
Carboxen. We suspect poorer desorption efficiency had greater influence, because menthol is 
small enough (at approximately 4 Å in diameter) to diffuse into the micropores (7–10 Å in 
diameter) of the Carboxen, yet has a polarity high enough to hinder rapid desorption. This 
explanation is supported by substantially higher carryover seen for the Carboxen/PDMS. 
Although the performance of the PDMS/DVB and CW/DVB were comparable, the 65 μm 
PDMS/DVB was selected to prepare all samples and standards because it proved to be the 
more rugged of the two coatings.
No significant carryover effect was observed throughout this study. To ensure that any 
possible analyte residue was removed from the SPME fiber and assembly between analyses, 
the SPME needle was intentionally kept in the GC inlet (250 °C) for the entire run. In 
addition, a blank run was always carried out immediately after the highest level of 
calibration standard (10 μg/mL), and the resulting chromatograms showed non-detectable 
menthol signals.
3.5. Precision and Accuracy
Long-term assay precision and instrument stability were determined from QC sample data 
including the QC characterization batches. Table 2 shows the QC data over a 7-month 
period. With every sample run, a QC low and QC high sample pair bracketed the unknown 
specimens, for a total of 4 QCs per run. Long-term variability achieved over this period for 
the total menthol measurement was 5.5 % relative standard deviation (RSD) for the TQCL 
and 7.6 % RSD for TQCH. Free menthol measurement, results had a long-term variability of 
14.2 % RSD for the FQCL and 14.4 % RSD for the FQCH.
Assay accuracy was evaluated by measuring proficiency testing (PT) samples, consisting of 
1 mL synthetic urine samples spiked with menthol to four gravimetrically determined 
concentrations of 1.0, 3.0, 6.0, and 9.0 μg/mL. This PT concentration range corresponded to 
15 percentile to 80 percentile of the study population used for method verification in Section 
3.8. Samples were blind coded and randomized by a quality control officer and stored at 
−70 °C prior to analysis. At the start of the study and at six month intervals thereafter, five 
blind coded PT samples were analyzed and reported to the external quality control officer 
for evaluation. These PT sample results are summarized in Table 3 and are expressed in 
terms of percent difference. The lowest PT level had the high percentage error of −11.50% 
(accuracy of 88.5%), which is attributed to experimental error associated with handling 
losses. Percentage error for the 3.0 and 6.0 μg/mL were lower at −2.08 and 0.58, 
respectively. At the highest PT concentration, greater imprecision of −10.22% is attributed to 
variability of the least squares curve fit at the highest concentrations caused by weighting the 
data 1/x.
3.6. Specimen storage stability
To evaluate the long-term stability of specimens stored at −70 °C, 8 specimens were selected 
randomly and total menthol was measured again after a period of 4 months. Concentrations 
differed by +5.4% to −7.5% with an average of −1.3%. These differences were within the 
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range of method accuracy demonstrated for the QC samples, and no changes that 
significantly affected the menthol level in the specimens were observed during storage 
duration.
3.7. Recovery of menthol glucuronide
To ensure complete menthol glucuronide recovery, a synthetic urine solution of menthol 
glucuronic acid ammonium salt ( was made at 22.4 μg/mL (equivalent to 10 μg/mL menthol 
glucuronide) and included in 12 different specimen runs over a 7-month period. Menthol 
levels for these recovery samples averaged 10.6 μg/mL (6.4 % RSD), which was within the 
precision seen for the TQCH characterized at 8.81 μg/mL (7.6 % RSD).
3.8. Method verification
To verify the method, we analyzed free menthol and total menthol concentrations in urine 
specimens from 27 non-mentholated cigarette and 68 mentholated cigarette smokers. 
Urinary free menthol levels were lower among non-mentholated cigarette smokers; 63% of 
specimens from non-mentholated cigarette smokers had free menthol levels below the MDL 
of 0.002 μg/mL compared with 13% of specimens from mentholated cigarette smokers. 
However, all participants total menthol levels above the MDL. Results below the MDL were 
imputed as MDL/√2.[16] Creatinine-adjusted urinary menthol level was calculated as the 
ratio of the measured menthol to the measured creatinine concentration to adjust for varying 
degrees of hydration and to enable comparison of our results with those from other studies.
[17,18] The creatinine adjusted free menthol levels in these specimens were log normally 
distributed with a geometric mean of 0.001 mg/g and 0.002 mg/g. These low adjusted free 
menthol levels suggest that the UDP-glucuronosyltransferases process effectively 
metabolizes free menthol among smokers of non-mentholated and mentholated cigarettes.
Shown in Fig. 2 is a comparison of creatinine-adjusted total menthol levels between non-
mentholated cigarette smokers and mentholated cigarette smokers. All specimens from these 
two groups had total menthol levels higher than the MDL. Values ranged between 0.041 and 
9.70 μg/mL among non-mentholated cigarette smokers and 0.330 and 38.0 μg/mL among 
mentholated cigarettes smokers. Distributions were log normal with a geometric mean of 
1.07 mg/g creatinine for non-mentholated cigarette smokers and 3.69 mg/g for mentholated 
cigarette smokers, with means significantly different (Wilcoxon / Kruskal-Wallis test, p < 
0.0001). The majority of urinary menthol was conjugated in all urines tested, and percent 
conjugation was not related to total menthol level. This finding is significant because it does 
not support the hypothesis that menthol contributes to smoking-related disease by saturating 
the UDP-glucuronosyltransferases process. [19]
4. Summary and Conclusions
Although this quantitative method for analysis of free and total menthol in human urine 
provides high sample throughput similar to other methods, its sample preconcentration 
minimizes carryover from the SPME fiber assembly, thus broadening the dynamic range to 5 
orders of magnitude and lowering the MDL to single unit ng/mL range. In addition, assay 
precision better than 7.6% and accuracy better than 88.5% is typically achieved.
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This method was verified by comparing urinary menthol levels from 27 smokers of non-
mentholated cigarettes with 68 smokers of mentholated cigarettes. Urinary menthol in both 
groups was generally more than 99% conjugated. On average, urinary menthol levels were 
three times higher for mentholated cigarette smokers than for non-mentholated cigarette 
smoker, confirming that smoking mentholated cigarettes increases menthol exposure levels. 
Moreover, there was no indication of saturation of the UDP-glucuronosyltransferases 
process among the mentholated cigarette smokers. This method will be used for further 
investigations of menthol as an independent factor in affecting racial/ethnic preference, 
nicotine dependence, smoking topography, and carcinogen exposure.
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Typical selected ion chromatograms of total menthol measurement in a urine specimen: 
panel A is a mass chromatogram for m/z 138 produced by 0.86 μg/mL menthol; panel B is 
the mass chromatogram for m/z 142 produced by the internal standard d4-menthol.
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Comparison of creatinine adjusted total menthol concentration among non-mentholated 
cigarette smokers (N=27) and mentholated cigarette smokers (N= 68). Geometric mean and 
95% confidence intervals are plotted in log scale. The threshold p-value corresponds to a 
Wilcoxon / Kruskal-Wallis test comparing the population means.
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Table 1
SPME fiber selection




synthetic urine (20 
μg/mL) urine (~7 μg/mL)
65 μm PDMS/DVB 3.0 2.0 1.7
75 μm Carboxen/PDMS 1 1 1
65 μm CW/DVB 2.8 1.7 2.1
b. Percent carryover in μg/mL.
Fiber ID Matrix
water (20 μg/mL) synthetic urine (20 μg/mL) urine (~7 μg/mL)
65 μm PDMS/DVB 0.02 0.03 0.02
75 μm Carboxen/PDMS 0.18 0.25 0.14
65 μm CW/DVB 0.005 0.004 N/A
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